Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIa trial of an inactivated quadrivalent enterovirus vaccine in children aged 6-71 months
CTR20262075Phase 3Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jun 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent inactivated enterovirus vaccine (Vero cell), sponsored by Sinovac Biotech Ltd.. Started Jun 2026; status: active.
02
Drugs
quadrivalent inactivated enterovirus vaccine (Vero cell)
Beyond the preview
Go deeper on CTR20262075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262075.